Find trials
Search tips

Reducing 30-day Readmissions in Patients With Heart Failure Through Pharmacist Discharge Medication Services

Overview

About this study

Patients admitted for heart failure that are provided discharge medication services by a pharmacist are less likely to be readmitted within 30 days of primary admission.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Diagnosis of heart failure, discharged from any medical service

Exclusion Criteria:

  • Unwilling to participate, discharged to nursing/rehab facility, non-English speaking, resident unavailable

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

La Crosse, Wis.

Mayo Clinic principal investigator

Sarah Lessard

Closed for enrollment

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20261266

Mayo Clinic Footer